[
    "{\"step_by_step_thinking\": \"Verubecestat is a BACE1 inhibitor that was developed as a potential treatment for Alzheimer's Disease. BACE1 is an enzyme involved in the production of amyloid-beta, which is a protein that forms plaques in the brains of individuals with Alzheimer's Disease. By inhibiting BACE1, verubecestat aims to reduce the production of amyloid-beta and potentially slow down the progression of the disease. However, clinical trials of verubecestat have shown mixed results. In one Phase 3 trial, verubecestat did not demonstrate a significant benefit in terms of cognitive function or disease progression compared to placebo. As a result, the trial was discontinued. Based on these findings, the answer to the question is B. no, verubecestat is not effective for Alzheimer's Disease.\", \"answer_choice\": \"B\"}"
]